Contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177Lu/90Y-DOTATOC and 213Bi-DOTATOC radiopeptide therapy - Giesel, F L; Wulfert, S; Zechmann, C M (Exp Oncol, 2013)
et al.